Durgesh Vasant Nadkarni

Title: Durgesh Vasant Nadkarni: Innovator in Antibody Drug Conjugates

Introduction

Durgesh Vasant Nadkarni is a notable inventor based in Old Lyme, Connecticut. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody drug conjugates. With a total of 2 patents, his work has advanced the methods used in drug purification and peptide conjugate preparation.

Latest Patents

Nadkarni's latest patents include innovative methods for the purification of antibody drug conjugates. One patent focuses on the purification process using a sodium phosphate gradient, which effectively removes high molecular weight species, particularly aggregates, from antibody drug conjugate preparations. This method involves contacting the preparations with hydroxyapatite resin and selectively eluting the ADC using a sodium phosphate gradient. Another patent details processes for preparing peptide conjugates and linkers, providing a process for creating compounds of Formula 5b and their intermediates, as well as novel classes of compounds useful in these processes.

Career Highlights

Durgesh Vasant Nadkarni is currently employed at Pfizer Corporation, where he continues to innovate in the biopharmaceutical sector. His work has been instrumental in enhancing the efficacy and safety of therapeutic agents.

Collaborations

Nadkarni collaborates with esteemed colleagues such as Jeffry R Borgmeyer and He Meng, contributing to a dynamic research environment that fosters innovation.

Conclusion

Durgesh Vasant Nadkarni's contributions to the field of antibody drug conjugates and peptide conjugate preparation highlight his role as a leading inventor in biopharmaceuticals. His patents reflect a commitment to advancing medical science and improving patient outcomes.